Patents by Inventor Daniel Umbricht

Daniel Umbricht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORGANIC COMPOUNDS
    Publication number: 20150272929
    Abstract: The invention concerns the use an mGluR modulator, e.g.
    Type: Application
    Filed: June 11, 2015
    Publication date: October 1, 2015
    Inventors: Daniel UMBRICHT, Baltazar Gomez-Mancilla, Fabrizio Gasparini, Therese Di Paolo
  • USE OF METABOTROPIC GLUTAMATE RECEPTORS
    Publication number: 20140187600
    Abstract: The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of cognitive dysfunction.
    Type: Application
    Filed: March 7, 2014
    Publication date: July 3, 2014
    Inventors: Ralf GLATTHAR, Donald JOHNS, Daniel UMBRICHT
  • METHOD FOR PREDICTING CLINICAL BENEFIT IN THE TREATMENT OF NEURODEVELOPMENTAL, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS
    Publication number: 20140065610
    Abstract: An in vitro method of predicting whether a patient, having a neurodevelopmental, neurological or neuropsychiatric disorder, will derive a clinical benefit if treated with a glycine reuptake inhibitor (GRI), via determination of the protein concentration of one, two, three, four five or six members of the complement factor H family or a mixture or a combination thereof and comparison against a representative value, wherein a higher value of the protein concentration in the patient's sample against the representative value is indicative of a patient whom will derive clinical benefit from treatment with GRI.
    Type: Application
    Filed: August 21, 2012
    Publication date: March 6, 2014
    Inventors: Laurent Essioux, Carsten Horn, Johann Karl, Peter Kastner, Fabian Model, Giuseppe Palermo, Christina Rabe, Daniel Umbricht, Gabriel Vargas, Anne Vogt
  • USE OF METABOTROPIC GLUTAMATE RECEPTORS
    Publication number: 20120309742
    Abstract: The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of cognitive dysfunction.
    Type: Application
    Filed: August 8, 2012
    Publication date: December 6, 2012
    Inventors: Ralf GLATTHAR, Donald JOHNS, Daniel UMBRICHT
  • ORGANIC COMPOUNDS
    Publication number: 20100249136
    Abstract: The invention concerns the use an mGluR modulator, e.g.
    Type: Application
    Filed: October 9, 2008
    Publication date: September 30, 2010
    Inventors: Daniel Umbricht, Baltazar Gomez-Mancilla, Fabrizio Gasparini, Therese Di Paolo
  • USES OF METABOTROPIC GLUTAMATE RECEPTORS
    Publication number: 20100041641
    Abstract: The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of cognitive dysfunction.
    Type: Application
    Filed: September 10, 2007
    Publication date: February 18, 2010
    Inventors: Glatthar Ralf, Donald Johns, Daniel Umbricht